2min chapter

The Gillett Health Podcast cover image

Big Pharma | The Gillett Health Podcast #34

The Gillett Health Podcast

CHAPTER

The Rise of Pharmaceutical Advertising in the United States

The average number of studies that are done on a specific drug has decreased significantly for stage two and stage three data. But I wouldn't necessarily say they get approved easier. There is just literally not a reason for other centers other than the ones that get funding often from the drug company to run a study like that. It's interesting with the prevalence of pharmaceutical advertising. You want the money to actually go towards funding new studies, not for the investors in the company, not for advertising.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode